Scope 1, 2, and 3 greenhouse gas (GHG) emissions
The company has an opportunity to reduce its scope 1 and 2 greenhouse gas emissions, as well as to disclose a time-bound target for their reduction. They should also report progress against these targets. Moreover, the company’s scope 1 and 2 emissions targets can be aligned with a 1.5-degree trajectory.
Additionally, it has an opportunity to reduce its scope 3 greenhouse gas emissions and report progress against these targets. Similarly, the company’s scope 3 emissions targets have the potential to be aligned with a 1.5-degree trajectory.
Animal welfare
While the company has a target that addresses animal welfare issues in its supply chain, it has an opportunity to make it applicable to all species, geographies and products.
Antibiotic use and growth promoting substances
While the company discloses its goal to eliminate the use of antibiotics defined by the WHO as Highest Priority Critically Important Antibiotics (HPCIAs), it has an opportunity to disclose targets to phase out the prophylactic use of antibiotics across all species, geographies and products, and report against them.
Ecosystem conversion
The company has an opportunity to disclose activities and time-bound targets to achieve conversion-free supply chains.
Food loss and waste
The company has the chance to disclose its FLW reduction targets and report on the progress made towards these targets. Furthermore, it has an opportunity to align its FLW reduction goals with SDG12.3, which aims for a 50% reduction by 2030.
Soil health and agrobiodiversity
The company has an opportunity to disclose a target to improve soil health in its production or sourcing practices and report progress against it.
Water withdrawal
The company has an opportunity to enhance its disclosures relating to water use and withdrawal.